Brief: Effector Therapeutics Announces It Will Wind Down Operations
24/06/2024 12:01
June 24 (Reuters) - eFFECTOR Therapeutics Inc EFTR.O :
* EFFECTOR THERAPEUTICS ANNOUNCES IT WILL WIND DOWN
OPERATIONS AS
IT SEEKS STRATEGIC ALTERNATIVES AND EXPECTS TO BE DELISTED FROM
NASDAQ
* EFFECTOR THERAPEUTICS INC - HAS TERMINATED ITS EMPLOYEES
* EFFECTOR THERAPEUTICS INC: APPOINTED CRAIG R. JALBERT AS
CEO,
PRESIDENT, TREASURER AND SECRETARY, AND SOLE MEMBER OF BOARD
Source text for Eikon: ID:nGNX2YNXmP
Further company coverage: EFTR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Effector Therapeutics
See all newsBrief: Effector Therapeutics Expects To Incur One-Time Charges And Cash Expenditures
Brief: Effector Therapeutics Announces It Will Wind Down Operations
Brief: Effector Therapeutics To Collaborate With The Dana-Farber Cancer Institute
eFFECTOR Therapeutics Inc reports results for the quarter ended in January - Earnings Summary
Brief: eFFECTOR Therapeutics Enters Into An At The Market Offering Agreement With H.C. Wainwright